期刊文献+

大剂量支气管动脉灌注化疗栓塞与全身静脉化疗治疗晚期非小细胞肺癌疗效的对比研究 被引量:5

Comparative study on high-dose bronchial arterial infusion chemotherapy versus systemic intravenous chemotherapy in the treatment of advanced non-small cell lung cancer
原文传递
导出
摘要 目的:比较大剂量支气管动脉灌注化疗栓塞和全身静脉化疗治疗晚期非小细胞肺癌的临床疗效。方法:选择2015年6月至2019年6月我院收治的接受支气管动脉化疗栓塞术或全身静脉化疗的肺癌患者115例,其中支气管动脉化疗栓塞组55例(试验组),全身静脉化疗组60例(对照组),观察比较两组肿瘤局部控制/缓解率、并发症、生活质量及生存时间。结果:接受支气管动脉化疗栓塞术的患者中位生存时间为567 d,接受全身静脉化疗的患者中位生存时间为544 d(P=0.951)。试验组和对照组的肿瘤控制率分别为80.1%和78.3%(P=0.196),肿瘤缓解率分别为70.9%和51.7%(P=0.035),严重并发症发生率分别为4.0%和15.0%(P=0.038)。两组患者术后生活质量均显著提高(P<0.001)。结论:对于晚期不可切除的非小细胞肺癌患者,大剂量支气管动脉灌注化疗栓塞治疗可以提高肿瘤局部缓解率,降低严重并发症发生率,提高患者生活质量。 Objective:To compare the effect of high-dose bronchial arterial infusion chemotherapy with that of systemic intravenous chemotherapy on the treatment of advanced non-small cell lung cancer(NSCLC).Methods:From June 2015 to June 2019,a total of 115 patients with unresectable NSCLC received high-dose bronchial arterial infusion chemotherapy or systemic intravenous chemotherapy in our hospital,of whom 55 patients were treated with high-dose bronchial arterial infusion chemotherapy group(experimental group)and 60 with systemic intravenous chemotherapy(control group).The overall survival time,complications,local tumor control or remission rate and life quality of the patients were studied and compared between the two groups.Results:The median overall survival time in the experimental group and the control group was 567 days and 544 days(P=0.951),respectively.The local tumor control rates were 80.1%and 78.3%(P=0.196),and the local tumor remission rates were 70.9%and 51.7%in the two groups,respectively.The incidence of severe complications was 4%and 15.0%(P=0.038).Patients'quality of life was significantly improved in the two groups(P<0.001).Conclusion:For patients with advanced NSCLC,the treatment strategy of high-dose bronchial arterial infusion chemotherapy may provide a better local tumor response rate,reduce the incidence of chemotherapy related complications,and improve the patients'quality of life.
作者 郑晓霆 景文冬 时广伟 金星宇 许晓海 ZHENG Xiaoting;JING Wendong;SHI Guangwei;JIN Xingyu;XU Xiaohai(Department of Oncology,Tianchang Chinese Medicine Hospital,Tianchang 239300,China)
出处 《现代医学》 2023年第2期216-219,共4页 Modern Medical Journal
关键词 非小细胞肺癌 大剂量 支气管动脉灌注化疗栓塞 静脉化疗 non-small cell lung cancer high dose bronchial arterial infusion chemotherapy systemic intravenous chemotherapy
作者简介 郑晓霆(1980-),男,安徽天长人,副主任医师。E-mail:82666968@qq.com
  • 相关文献

参考文献2

二级参考文献11

共引文献42

同被引文献76

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部